Business Description
BiOptic Inc
ISIN : TW0006850001
Total Employee Number:
50Description
BiOptic Inc is a biotechnology instrumentation company that develops scientific products for research and clinical applications. It serves professionals and laboratories dedicated to life science research, clinical diagnostics, pharmaceutical and food industries, animal husbandry, and agriculture, performing diagnostic molecular genetic analyses.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.98 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | 3.43 | |||||
Interest Coverage | 19.75 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 6.66 | |||||
Beneish M-Score | -3.73 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.9 | |||||
3-Year EBITDA Growth Rate | -34.3 | |||||
3-Year EPS without NRI Growth Rate | -71.4 | |||||
3-Year FCF Growth Rate | 11.8 | |||||
3-Year Book Growth Rate | 1.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.27 | |||||
9-Day RSI | 43.01 | |||||
14-Day RSI | 44.51 | |||||
3-1 Month Momentum % | -9.09 | |||||
6-1 Month Momentum % | -19.17 | |||||
12-1 Month Momentum % | -15.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.26 | |||||
Quick Ratio | 4.54 | |||||
Cash Ratio | 3.93 | |||||
Days Inventory | 534.84 | |||||
Days Sales Outstanding | 38.99 | |||||
Days Payable | 24.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.84 | |||||
Dividend Payout Ratio | 7.5 | |||||
3-Year Dividend Growth Rate | -6.2 | |||||
Forward Dividend Yield % | 0.84 | |||||
5-Year Yield-on-Cost % | 0.86 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 0.9 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59.99 | |||||
Operating Margin % | 16.61 | |||||
Net Margin % | 0.52 | |||||
EBITDA Margin % | 10.59 | |||||
FCF Margin % | 36.76 | |||||
OCF Margin % | 37.84 | |||||
ROE % | 0.27 | |||||
ROA % | 0.21 | |||||
ROC (Joel Greenblatt) % | 2.1 | |||||
ROCE % | 1.46 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 855 | |||||
PE Ratio without NRI | 855 | |||||
Price-to-Owner-Earnings | 29.24 | |||||
PS Ratio | 4.79 | |||||
PB Ratio | 2.56 | |||||
Price-to-Tangible-Book | 2.63 | |||||
Price-to-Free-Cash-Flow | 13.05 | |||||
Price-to-Operating-Cash-Flow | 12.68 | |||||
EV-to-EBIT | 133.8 | |||||
EV-to-EBITDA | 42.26 | |||||
EV-to-Revenue | 4.47 | |||||
EV-to-FCF | 12.48 | |||||
Price-to-GF-Value | 0.76 | |||||
Price-to-Projected-FCF | 2.32 | |||||
Price-to-Graham-Number | 10 | |||||
| Price-to-Net-Current-Asset-Value | 6.31 | |||||
| Price-to-Net-Cash | 32.26 | |||||
Earnings Yield (Greenblatt) % | 0.75 | |||||
FCF Yield % | 7.67 | |||||
Forward Rate of Return (Yacktman) % | -8.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BiOptic Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 236.13 | ||
| EPS (TTM) (NT$) | 0.04 | ||
| Beta | -0.2138 | ||
| 3-Year Sharpe Ratio | -0.41 | ||
| 3-Year Sortino Ratio | -0.57 | ||
| Volatility % | 28.29 | ||
| 14-Day RSI | 44.51 | ||
| 14-Day ATR (NT$) | 0.781423 | ||
| 20-Day SMA (NT$) | 34.5225 | ||
| 12-1 Month Momentum % | -15.2 | ||
| 52-Week Range (NT$) | 33.25 - 51.7 | ||
| Shares Outstanding (Mil) | 33.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BiOptic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BiOptic Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.300000 Cash Dividend | 2025-08-20 | 44.91 (+0.82%) | ||
| 1.1:1 Stock Split | 2025-08-20 | 44.91 (+0.82%) | ||
| TWD 0.181818 Cash Dividend | 2024-08-21 | 51.64 (+8.05%) | ||
| 1.13382:1 Stock Split | 2024-08-21 | 51.64 (+8.05%) | ||
| 1.1:1 Stock Split | 2023-08-24 | 40.02 (+1.86%) | ||
| 1.1:1 Stock Split | 2022-08-25 | 37.11 (+0.36%) |
Show
Entries
BiOptic Inc Frequently Asked Questions
What is BiOptic Inc(ROCO:6850)'s stock price today?
The current price of ROCO:6850 is NT$34.20. The 52 week high of ROCO:6850 is NT$51.70 and 52 week low is NT$33.25.
When is next earnings date of BiOptic Inc(ROCO:6850)?
The next earnings date of BiOptic Inc(ROCO:6850) is .
Does BiOptic Inc(ROCO:6850) pay dividends? If so, how much?
The Dividend Yield %  of BiOptic Inc(ROCO:6850) is 0.84% (As of Today), Highest Dividend Payout Ratio of BiOptic Inc(ROCO:6850) was 7.5. The lowest was 0.2. And the median was 0.48. The  Forward Dividend Yield % of BiOptic Inc(ROCO:6850) is 0.84%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BiOptic Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers